Literature DB >> 6445528

Epidemiology and diagnosis of acute pelvic inflammatory disease.

D A Eschenbach.   

Abstract

Epidemiologic factors important in acute pelvic inflammatory disease (PID) are the pathogenic organisms Neisseria gonorrhoeae and Chlamydia trachomatis, less pathogenic mycoplasma, and endogenous aerobic and anaerobic bacteria. Other risk factors for PID include the number of sexual partners, previous PID, previous gonorrhea, and male gonorrhea. The patient's age, IUD use, and social factors may be dependent variables for the development of PID. The diagnosis is often difficult to establish; practical diagnostic methods include a careful history and physical examination, laboratory tests (particularly a cervical Gram stain), culdocentesis, and examination of the male. Laparoscopy should be used when the diagnosis is unclear.

Entities:  

Mesh:

Year:  1980        PMID: 6445528     DOI: 10.1097/00006250-198003001-00037

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Pelvic inflammatory disease: a family practice perspective.

Authors:  J W Sellors
Journal:  Can Fam Physician       Date:  1989-06       Impact factor: 3.275

2.  Mortality from sexually transmitted diseases in reproductive-aged women: United States, 1999-2010.

Authors:  Kara A McElligott
Journal:  Am J Public Health       Date:  2014-06-12       Impact factor: 9.308

3.  Salpingitis and cervicitis in uro-arthritis.

Authors:  U I Yli-Kerttula; J M Kataja; A H Vilppula
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

4.  Cefotaxime in the treatment of female pelvic soft tissue infections.

Authors:  S Roy; J Wilkins
Journal:  Infection       Date:  1985       Impact factor: 3.553

5.  Association of pelvic inflammatory disease (PID) with ectopic pregnancy and preterm labor in Taiwan: A nationwide population-based retrospective cohort study.

Authors:  Chun-Chung Huang; Chien-Chu Huang; Shao-Yi Lin; Cherry Yin-Yi Chang; Wu-Chou Lin; Chi-Hsiang Chung; Fu-Huang Lin; Chang-Huei Tsao; Chun-Min Lo; Wu-Chien Chien
Journal:  PLoS One       Date:  2019-08-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.